Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

Philip H. Keiser, Michael G. Sension, Edwin DeJesus, Allan Rodriguez, Jeffrey F. Olliffe, Vanessa C. Williams, John H. Wakeford, Jerry W. Snidow, Anne D. Shachoy-Clark, Julie W. Fleming, Gary E. Pakes, Jaime E. Hernandez

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences